Facebook Linkedin Twitter

Reimbursement

Rare Parents Tackling Rare Diseases
News & Features

Rare Parents Tackling Rare Diseases

Chris Anderson -
0
Nurse with masks
Coronavirus

Valunomics: Key Lessons from Covid—We Need to Value Diagnostics

Kathy Vuksanaj -
0
Genetic research, liquid biopsy conceptual illustration
Molecular Dx

Agendia to Distribute Inivata’s RaDaR MRD and Cancer Recurrence LBx in U.S. and Europe

Chris Anderson -
0
Genetic Counseling for All
News & Features

Genetic Counseling for All

Kathy Vuksanaj -
0
Invitae to Acquire Clear Genetics for $50M, Adding Chatbots for Genetic Counseling
News & Features

Invitae to Acquire Clear Genetics for $50M, Adding Chatbots for Genetic Counseling

Alex Philippidis -
0
CellMax Life aims to win FDA approval for its circulating tumor cell (CTC) blood test designed to detect colorectal cancer. The test has been marketed for two yers in Asia
Molecular Dx

CellMax Life Launches Clinical Study for Colorectal Cancer CTC Blood Test

Clinical OMICs Staff Writer -
0
Myriad Genetics plans to acquire Counsyl for $375 million in cash and stock
Molecular Dx

Myriad to Acquire Counsyl for $375M, Raising Presence in Women’s Health

Clinical OMICs Staff Writer -
0
Genetic testing concept, DNA icon, medical doctor, isolated on white
News & Features

Anthem, UnitedHealthcare Move toward Quicker Prior Authorizations for Some Tests

Alex Philippidis -
0
NAS Urges “Rapid Learning System” to Accelerate Personalized Medicine
News & Features

NAS Urges “Rapid Learning System” to Accelerate Personalized Medicine

Clinical OMICs Staff Writer -
0
The complexity of reimbursement for all healthcare procedures and services is something that places a great burden on the healthcare delivery system. It would seem that reform in this regard should be a priority
News & Features

To Pay or Not to Pay? Is That the Question?

Sharon F. Terry -
0
12Page 1 of 2

Related Content

Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine